Hims & Hers Health, Inc.
Hims & Hers Health Reports Strong Q4 2023 Financial Results and Outlook
Summary
Hims & Hers Health, Inc. announced its financial results for the quarter and full year ended December 31, 2023, reporting a 65% year-over-year revenue increase to $872.0 million, reaching net income of $1.2 million for Q4 2023, and achieving Adjusted EBITDA profitability of $20.6 million. The company's subscribers grew to 1.5 million by the end of Q4 2023, up 48% year-over-year. The company provided Q1 and full-year 2024 guidance, expecting revenue between $1.17 billion to $1.20 billion and Adjusted EBITDA between $100 million to $120 million.
Profitelligence Alerts
Get alerts for HIMS
Be first to know when Hims & Hers Health, Inc. files with the SEC.
Filing Categories
Exhibits (2)
Advertisement
About Hims & Hers Health, Inc.
Hims & Hers Health, Inc. is a telehealth service provider that aims to simplify and enhance healthcare access for consumers. The company specializes in personal care and wellness products and services, offering both prescription and over-the-counter solutions. With a focus on destigmatizing health and wellness issues, Hims & Hers addresses areas such as dermatology, sexual health, hair care, and mental wellness, appealing to a broad demographic looking for convenient and private healthcare options. By facilitating online consultations with licensed medical professionals, the company allows users to receive medical advice, treatments, and prescriptions, all accessible from the comfort of their homes. Hims & Hers plays a significant role in the growing digital healthcare market, leveraging technology to provide more accessible and personalized healthcare experiences. Headquartered in San Francisco, the company capitalizes on the increase in demand for telehealth services, buoyed by advancements in digital health trends and the expanding e-commerce space for healthcare solutions.
Official SEC Documents
Advertisement